My site

DURHAM, N.C. -Thursday, March 16th 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- Bioventus, a global leader in orthobiologics, today announced it will commission an innovative series of real-world evidence, direct-to-patient studies to further validate the ability of its EXOGEN Ultrasound Bone Healing System to mitigate the risk of a fracture progressing to nonunion in the presence of known risk factors. FDA PMA approved in 1994, EXOGEN has provided treatment to more than 1 million patients worldwide for more than 20 years and has a long clinical history. The product uses safe, effective low-intensity pulsed ultrasound (LIPUS) to help stimulate the body’s natural healing process.1

Recent publications analyzing data from a large registry of almost 8,000 fractures treated with EXOGEN suggest that the device supports healing fractures in patients despite the presence of associated comorbidities or medication use.2,3,4 This new clinical research, known as t ... Read more »

 Provides Open Framework to Enable Diverse Innovation from an Industry-wide Ecosystem

RICHARDSON, Texas-Monday, March 20th 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- Mavenir, the global leaders in software-defined infrastructure solutions with a world-leading installed base of advanced messaging solutions that support more than 3.5 billions of subscribers across 350 operators, today announced the launch of its cloud-based Rich Communication Services (RCS) Platform and Hub, further expanding its globally deployed suite of flagship RCS solutions that support tens of millions of subscribers worldwide.

With its new RCS Platform and Hub, Mavenir provides Communications Service Providers (CSPs) with an innovative approach to quickly and efficiently deploy secure and advanced communications, while capitalizing on new monetization services but without the high costs and complexity associated with large-scale network infrastructure projects.

Th ... Read more »

Dubai, United Arab Emirates -Monday, March 20th 2017 [ ME NewsWire ]

HH Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of UAE and Ruler of Dubai, has inaugurated the 200 megawatt (MW) second phase of the Mohammed bin Rashid Al Maktoum Solar Park. The project reflects a new era in the excellence and leadership of the UAE, as it increases the share of clean and renewable energy. The inauguration coincided with the International Day of Happiness.

This phase of the solar park is the first and largest solar-energy project in the region, based on the Independent Power Producer (IPP) model. It was accomplished through a partnership between DEWA and the consortium led by ACWA Power from Saudi Arabia, the main developer of the project, and TSK from Spain, the main contractor, with an investment of AED 1.2 billion. This phase can generate clean energy for 50,000 residences in Dubai, and will reduce 214,000 tonnes of carbon emissions ann ... Read more »

Celebrating Leading Innovators in Global Financial Services

CHICAGO-Monday, March 20th 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- Entries are now open for the 2017 BAI Global Innovation Awards. With 13 honors spanning 10 categories, BAI’s Awards celebrate the greatest achievements and innovations in the financial services industry. Nominations will be accepted through Friday, April 28, 2017, with a shortlist of nominations for each category announced by late summer. Winners will be recognized at BAI Beacon 2017 (Oct. 4-5) in Atlanta.

BAI’s Global Innovation Awards program serves as a catalyst for worldwide financial services innovation. Since 2011, the BAI Global Innovation Awards have provided a global platform to inspire and connect forward-thinking financial services organizations and leaders who are driving positive change and moving the industry forward, positively impacting customer experience, efficiency and profitability.

The 20 ... Read more »

● In the RE-CIRCUIT® trial, there were less major bleeding and fewer serious adverse events with uninterrupted Pradaxa® than with uninterrupted warfarin1,2

● Patients studied in the trial were reflective of those undergoing catheter ablation in routine clinical practice, providing highly relevant data to treating physicians1,2

● Data presented at the ACC Congress 2017 and published in the New England Journal of Medicine (NEJM) 1,2

INGELHEIM, Germany-Monday, March 20th 2017 [ ME NewsWire ]

(BUSINESS WIRE)-- Important new data from the RE-CIRCUIT® study show a better safety profile for Pradaxa® (dabigatran etexilate) compared to warfarin in atrial fibrillation (AF) patients undergoing catheter ablation. AF patients who underwent catheter ablation while being treated with uninterrupted Pradaxa® experienced less major bleeding and fewer serious adverse events compared to those treated with uninterrupted warfarin. The results wer ... Read more »